InvestorsHub Logo
Followers 9
Posts 249
Boards Moderated 0
Alias Born 04/30/2010

Re: BearGator56 post# 25

Monday, 01/23/2017 4:36:56 PM

Monday, January 23, 2017 4:36:56 PM

Post# of 270
Just go to their website and look at the past CEO presentations, as well as some of the interviews with the drug users and you will be impressed. I was especially touched by one women who said she had SPMS so bad she was considering euthanasia. But after taking the drug for some time she is back to driving her car, among other things.
And their plan is simple. Finalize the 2B trial in April, report on the results by September, and either partner with big pharma, or preferably sell the company to big pharma in the 4th quarter.
Other pertinent info is that they believe the market for the drug for SPMS is $7 billion+. There is no current drug on the market for that condition.
A number I researched that is an average multiple for the sale of small biotechs is 4, therefore if it was agreed that sales for the product annually would be $1 billion, the company would sell for $4 billion, as I understand it.
If the current options available are exercised there will be just under 250,000,000 shares outstanding at that point.
I can't tell you that what I've written here is positively, absolutely right, but it is what I've found with my research.